Cell Line : HH[HUMANLYMPHOMA]
Cellosaurus Index : CVCL_1280
Cellosaurus ID : HH[HUMANLYMPHOMA]
CTRP2 Name
, GDSC1 Name
, GDSC2 Name
: HH
CCLE Name
: HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HH[HUMANLYMPHOMA] | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| HH[HUMANLYMPHOMA] | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | AA-COCF3 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| HH[HUMANLYMPHOMA] | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| HH[HUMANLYMPHOMA] | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| HH[HUMANLYMPHOMA] | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| HH[HUMANLYMPHOMA] | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| HH[HUMANLYMPHOMA] | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| HH[HUMANLYMPHOMA] | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| HH[HUMANLYMPHOMA] | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| HH[HUMANLYMPHOMA] | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BI-2536 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| HH[HUMANLYMPHOMA] | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| HH[HUMANLYMPHOMA] | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HH[HUMANLYMPHOMA] | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| HH[HUMANLYMPHOMA] | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| HH[HUMANLYMPHOMA] | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| HH[HUMANLYMPHOMA] | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| HH[HUMANLYMPHOMA] | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| HH[HUMANLYMPHOMA] | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| HH[HUMANLYMPHOMA] | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| HH[HUMANLYMPHOMA] | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| HH[HUMANLYMPHOMA] | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| HH[HUMANLYMPHOMA] | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| HH[HUMANLYMPHOMA] | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| HH[HUMANLYMPHOMA] | COL-3 | CTRP2 | 0.0020 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| HH[HUMANLYMPHOMA] | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Crizotinib | GDSC1,GDSC2,CCLE | 0.0010 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Dabrafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| HH[HUMANLYMPHOMA] | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| HH[HUMANLYMPHOMA] | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0001 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | Dasatinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| HH[HUMANLYMPHOMA] | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| HH[HUMANLYMPHOMA] | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| HH[HUMANLYMPHOMA] | Entinostat | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| HH[HUMANLYMPHOMA] | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| HH[HUMANLYMPHOMA] | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Erlotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| HH[HUMANLYMPHOMA] | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| HH[HUMANLYMPHOMA] | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HH[HUMANLYMPHOMA] | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| HH[HUMANLYMPHOMA] | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| HH[HUMANLYMPHOMA] | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| HH[HUMANLYMPHOMA] | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK269962A | GDSC1 | 0.0098 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| HH[HUMANLYMPHOMA] | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| HH[HUMANLYMPHOMA] | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| HH[HUMANLYMPHOMA] | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| HH[HUMANLYMPHOMA] | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| HH[HUMANLYMPHOMA] | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| HH[HUMANLYMPHOMA] | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | L-685458 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | Lapatinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| HH[HUMANLYMPHOMA] | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | MG-132 | GDSC1,GDSC2,CTRP2 | 0.0006 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| HH[HUMANLYMPHOMA] | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| HH[HUMANLYMPHOMA] | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| HH[HUMANLYMPHOMA] | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| HH[HUMANLYMPHOMA] | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| HH[HUMANLYMPHOMA] | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| HH[HUMANLYMPHOMA] | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HH[HUMANLYMPHOMA] | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| HH[HUMANLYMPHOMA] | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| HH[HUMANLYMPHOMA] | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Nutlin-3a | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | NVP-TAE684 | GDSC1,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| HH[HUMANLYMPHOMA] | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HH[HUMANLYMPHOMA] | Oxaliplatin | GDSC2 | 0.0100 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Paclitaxel | GDSC1,GDSC2,CCLE | 0.0000 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | Parthenolide | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HH[HUMANLYMPHOMA] | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| HH[HUMANLYMPHOMA] | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | PHA-665752 | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| HH[HUMANLYMPHOMA] | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| HH[HUMANLYMPHOMA] | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| HH[HUMANLYMPHOMA] | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| HH[HUMANLYMPHOMA] | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| HH[HUMANLYMPHOMA] | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | RAF265 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | Rapamycin | GDSC1,GDSC2,CTRP2 | 0.0000 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| HH[HUMANLYMPHOMA] | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HH[HUMANLYMPHOMA] | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Saracatinib | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| HH[HUMANLYMPHOMA] | Selumetinib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HH[HUMANLYMPHOMA] | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HH[HUMANLYMPHOMA] | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HH[HUMANLYMPHOMA] | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HH[HUMANLYMPHOMA] | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| HH[HUMANLYMPHOMA] | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| HH[HUMANLYMPHOMA] | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| HH[HUMANLYMPHOMA] | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | Sorafenib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| HH[HUMANLYMPHOMA] | Tanespimycin | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0041 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| HH[HUMANLYMPHOMA] | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | TGX221 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| HH[HUMANLYMPHOMA] | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| HH[HUMANLYMPHOMA] | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| HH[HUMANLYMPHOMA] | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| HH[HUMANLYMPHOMA] | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Tozasertib | GDSC1 | 0.0078 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Tretinoin | GDSC1,CTRP2 | 0.0041 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HH[HUMANLYMPHOMA] | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HH[HUMANLYMPHOMA] | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| HH[HUMANLYMPHOMA] | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| HH[HUMANLYMPHOMA] | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | TW 37 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | UNC0638 | GDSC1,GDSC2 | 0.0050 | 40.0000 |
|
| HH[HUMANLYMPHOMA] | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| HH[HUMANLYMPHOMA] | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| HH[HUMANLYMPHOMA] | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| HH[HUMANLYMPHOMA] | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| HH[HUMANLYMPHOMA] | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| HH[HUMANLYMPHOMA] | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| HH[HUMANLYMPHOMA] | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| HH[HUMANLYMPHOMA] | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| HH[HUMANLYMPHOMA] | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| HH[HUMANLYMPHOMA] | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| HH[HUMANLYMPHOMA] | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| HH[HUMANLYMPHOMA] | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HH[HUMANLYMPHOMA] | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| HH[HUMANLYMPHOMA] | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | YK-4-279 | GDSC1,GDSC2 | 0.0200 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| HH[HUMANLYMPHOMA] | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| HH[HUMANLYMPHOMA] | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| HH[HUMANLYMPHOMA] | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| HH[HUMANLYMPHOMA] | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| HH[HUMANLYMPHOMA] | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| HH[HUMANLYMPHOMA] | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HH[HUMANLYMPHOMA] | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| HH[HUMANLYMPHOMA] | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC